Use of tetrahydrofolates in natural stereoisomeric form for the

Details Use of tetrahydrofolates in natural stereoisomeric form for the Use of tetrahydrofolates in natural stereoisomeric form for the

1998-06-11

2000-01-04

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31505

Patent

active

060110406

ABSTRACT:
This invention relates to the use of tetrahydrofolates in natural stereoisomeric form for the production of a pharmaceutical preparation suitable for influencing the homocysteine level, particularly for assisting the remethylation of homocysteine. Clinical areas of application include all anomalies of the homocysteine level, particularly the prevention and treatment of cardiovascular diseases and the prevention of neural tube deficiencies. The present invention also relates to pharmaceutical preparations comprising at least one compound selected from the group consisting of 5-formyl-(6S)-tetrahydrofolic acid, 5-methyl-(6S)-tetrahydrofolic acid, 5,10-methylene-(6R)-tetrahydrofolic acid, 5,10-methenyl-(6R)-tetrahydrofolic acid, 10-formyl-(6R)-tetrahydrofolic acid, 5-formimino-(6S)-tetra-hydrofolic acid or (6S)-tetrahydrofolic acid or pharmaceutically compatible salts thereof, together with pharmaceutically compatible active and adjuvant substances, for influencing the homocysteine level, particularly when a methylene tetrahydrofolate reductase deficiency exists, such as when thermolabile methylene tetrahydrofolate reductase exists for example.

REFERENCES:
patent: 5334535 (1994-08-01), Schlingmann et al.
Resch (ed.), Risikofaktor Homocystein Daten-Fakten-Strateien [Homocystein Risk Factor--Data-Facts-Strategies], Gesellschaft fur Medizinische Information ISBN 3-980 45 36-0-C. (1996).
Fortin et al., Clinical Biochemistry, 28(2):155-162, 1995.
Mills et al., Supplement Publication to the Ceres Form on Jun. 14, 1995, 1996, pp. 756S-760S.
Loehrer, F.M., Abstract from Arterioscler Thromb Vasc Bio., "Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease", 16:6, Jun. 1996, pp. 727-733.

Affiliated with

Also associated with

Rating

Use of tetrahydrofolates in natural stereoisomeric form for the does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of tetrahydrofolates in natural stereoisomeric form for the , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tetrahydrofolates in natural stereoisomeric form for the will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1072866